HRT Financial’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | -$2K | – | 2652 |
|
|
2025
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 2195 |
|
|
2024
Q4 | – | Sell |
-323
| Closed | -$5K | – | 2475 |
|
|
2024
Q3 | $5K | Sell |
323
-154
| -32% | -$2.38K | ﹤0.01% | 2092 |
|
|
2024
Q2 | $13K | Sell |
477
-1,081
| -69% | -$29.5K | ﹤0.01% | 1798 |
|
|
2024
Q1 | $467K | Buy |
+1,558
| New | +$467K | ﹤0.01% | 1233 |
|
|
2021
Q4 | – | Sell |
-513
| Closed | -$112K | – | 3199 |
|
|
2021
Q3 | $112K | Sell |
513
-568
| -53% | -$124K | ﹤0.01% | 2602 |
|
|
2021
Q2 | $250K | Buy |
+1,081
| New | +$250K | ﹤0.01% | 2166 |
|
|
2020
Q1 | – | Sell |
-399
| Closed | -$211K | – | 850 |
|
|
2019
Q4 | $211K | Buy |
399
+191
| +92% | +$101K | 0.01% | 870 |
|
|
2019
Q3 | $89K | Buy |
+208
| New | +$89K | ﹤0.01% | 1144 |
|